Skip to main content

Find Clinical Trials

Home
Conditions
Acute Myelogenous Leukemia

Clinical trial condition

Acute Myelogenous Leukemia

Explore clinical trials studying Acute Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.

154 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Acute Myelogenous Leukemia trial results

Completed

A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies

NCT00719836

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Chronic Disease, +19 more
Locations: The University of Chicago Hospitals Chicago, Illinois, United States

MD Anderson Cancer Center Houston, Texas, United States

Fred Hutchinson Cancer Center Seattle, Washington, United States

View Trial Details

Completed

Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies

NCT00270881

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +24 more
Locations: Keio University School of Medicine Tokyo, Japan

View Trial Details

Completed

Dose Escalation, Safety and Pharmacokinetic Study of SAR103168 in Patients Refractory/ Relapsed Acute Leukemias or High-risk Myelodysplastic Syndromes

NCT00981240

Conditions: Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Sanofi-Aventis Investigational Site Number 840003 Atlanta, Georgia, United States

Sanofi-Aventis Investigational Site Number 840002 New York, United States

Sanofi-Aventis Investigational Site Number 840001 Houston, Texas, United States

View Trial Details

Completed

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation

NCT00144677

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +28 more
Locations: Dana-Farber Cancer Center Boston, Massachusetts, United States

View Trial Details

Completed

PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP

NCT00088231

Conditions: Acute Myelogenous Leukemia, Agnogenic Myeloid Metaplasia, Blast Crisis, +19 more
Locations: M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Trial of Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00760084

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML

NCT00474006

Conditions: Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Asan Medical Center Seoul, Songpa-gu, South Korea

View Trial Details

Completed

A Risk-Oriented Therapeutic Strategy for Adult Acute Myelogenous Leukemia

NCT00400673

Conditions: Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: USC Ematologia Ospedali Riuniti di Bergamo Bergamo, BG, Italy

Divisione Ematologia Spedali Civili di Brescia Brescia, BS, Italy

Divisione di Ematologia e TMO Ospedale San Maurizio Bolzano, BZ, Italy

Ematologia Azienda Ospedaliera S. Croce e Carle Cuneo, CN, Italy

View Trial Details

Completed

A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

NCT00136461

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia

NCT00136422

Conditions: Acute Myelogenous Leukemia, Anemia, Anemia, Refractory, +11 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details